Energy tech firm Aspen Aerogels Q2 revenue falls

Aspen Aerogels

07/08/2025 11:38

Overview

Aspen Aerogels Q2 revenue falls to $78 mln from $117.8 mln year-over-year

Net loss of $9.1 mln includes $5.9 mln in restructuring charges

Adjusted EBITDA improves 98% quarter-over-quarter, reflecting cost structure reductions

Outlook

Aspen sees H2 2025 revenue between $140 mln and $160 mln

Company expects FY 2025 revenue of $297 mln to $317 mln

Aspen projects H2 2025 Adjusted EBITDA of $20 mln to $30 mln

Company plans to maintain net cash position by year-end

Result Drivers

COST STRUCTURE REDUCTIONS - Aspen attributes 98% improvement in adjusted EBITDA QoQ to reductions in fixed cost structure

THERMAL BARRIER GROWTH - Thermal barrier segment revenue increased 13% QoQ, contributing to overall performance

ENERGY INDUSTRIAL DECLINE - Energy industrial segment revenue decreased 24% QoQ, impacting total revenue

Key Details

Metric
Beat/Miss
Actual
Consensus Estimate
Q2 EPS
-$0.11
Q2 Net Income
-$9.10 mln


Analyst Coverage

The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 5 "strong buy" or "buy", 3 "hold" and no "sell" or "strong sell"

The average consensus recommendation for the specialty chemicals peer group is "buy"

Wall Street's median 12-month price target for Aspen Aerogels Inc is $9.50, about 13.3% above its August 6 closing price of $8.24

Press Release: ID:nGNXZ2w4

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)